Recent progress in herpes simplex virus immunobiology and vaccine research
about
Using HSV-1 genome phylogenetics to track past human migrationsTowards a rational design of an asymptomatic clinical herpes vaccine: the old, the new, and the unknownHSV-2: in pursuit of a vaccineThe C terminus of the B5 receptor for herpes simplex virus contains a functional region important for infection.Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal gangliaInhibition of MHC class I is a virulence factor in herpes simplex virus infection of mice.Recent advances in vaccine development for herpes simplex virus types I and IIOcular herpes simplex virus: how are latency, reactivation, recurrent disease and therapy interrelated?Phase I Dose-Escalation Study of a Monovalent Heat Shock Protein 70-Herpes Simplex Virus Type 2 (HSV-2) Peptide-Based Vaccine Designed To Prime or Boost CD8 T-Cell Responses in HSV-Naive and HSV-2-Infected SubjectsHerpes simplex virus type 1 penetrates the basement membrane in human nasal respiratory mucosaAgents and strategies in development for improved management of herpes simplex virus infection and disease.Characterization of the IFN-gamma T-cell responses to immediate early antigens in humans with genital herpesImmunization with a dominant-negative recombinant Herpes Simplex Virus (HSV) type 1 protects against HSV-2 genital disease in guinea pigs.Construction and properties of a herpes simplex virus 2 dl5-29 vaccine candidate strain encoding an HSV-1 virion host shutoff protein.Babassu aqueous extract (BAE) as an adjuvant for T helper (Th)1-dependent immune responses in mice of a Th2 immune response-prone strain.Herpes simplex virus and the chemokines that mediate the inflammation.Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.Herpes simplex virus-induced epithelial damage and susceptibility to human immunodeficiency virus type 1 infection in human cervical organ culture.Multiplex sequencing of seven ocular herpes simplex virus type-1 genomes: phylogeny, sequence variability, and SNP distributionA wide extent of inter-strain diversity in virulent and vaccine strains of alphaherpesviruses.A case of Ramsay Hunt-like syndrome caused by herpes simplex virus type 2.Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.Herpes keratitis.A single intramuscular vaccination of mice with the HSV-1 VC2 virus with mutations in the glycoprotein K and the membrane protein UL20 confers full protection against lethal intravaginal challenge with virulent HSV-1 and HSV-2 strains.Genome editing and the next generation of antiviral therapy.Bovine herpesvirus glycoprotein D: a review of its structural characteristics and applications in vaccinologyMucosal administration of CpG oligodeoxynucleotide elicits strong CC and CXC chemokine responses in the vagina and serves as a potent Th1-tilting adjuvant for recombinant gD2 protein vaccination against genital herpesDiversity of the CD8+ T-cell response to herpes simplex virus type 2 proteins among persons with genital herpes.Virus-specific immune memory at peripheral sites of herpes simplex virus type 2 (HSV-2) infection in guinea pigs.Immunization with herpes simplex virus 2 (HSV-2) genes plus inactivated HSV-2 is highly protective against acute and recurrent HSV-2 diseaseDesign and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c miceThe HIV-1 Tat protein induces the activation of CD8+ T cells and affects in vivo the magnitude and kinetics of antiviral responses.Development of a glycoprotein D-expressing dominant-negative and replication-defective herpes simplex virus 2 (HSV-2) recombinant viral vaccine against HSV-2 infection in miceT cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.Immunization with a vaccine combining herpes simplex virus 2 (HSV-2) glycoprotein C (gC) and gD subunits improves the protection of dorsal root ganglia in mice and reduces the frequency of recurrent vaginal shedding of HSV-2 DNA in guinea pigs compaRelay of herpes simplex virus between Langerhans cells and dermal dendritic cells in human skin.CD1d Expression and Invariant NKT Cell Responses in Herpesvirus InfectionsApoptosis and antigen receptor function in T and B cells following exposure to herpes simplex virus
P2860
Q21090704-7061F52E-DF6B-4FCC-A908-2353113BBE30Q21296712-4EF1FB73-9F26-4FD0-B370-67BF91919675Q22306291-7A736203-B4BE-41B8-A3CA-CF126030B79DQ24529146-DF8DA007-81F0-4E2B-92A7-F0A4B0C55E62Q24685440-322DD3AC-8CEC-4108-907C-413770ED8224Q24817190-884536F9-88A6-4F80-A365-665093444F47Q26859623-62295EB9-E495-412D-8271-2BBD99E991CEQ27021069-8ACBE11F-2E90-4072-A487-B171799F2773Q27486108-FF4DC786-6CFC-475C-8212-876AB9EECEC8Q28742559-C64E962D-98FB-4954-B4DC-60A3BB43530AQ30350341-85E51259-5179-4ECD-8727-CF89B3981E60Q33248961-2AF62A3F-C746-4EE8-8947-F7E6B822BC9CQ33595097-D701A939-7DC8-4650-93C6-276A52A7015DQ33724497-7DD6CCA0-5F84-4B47-BDD7-CCD8A8381C1AQ33806434-F1A3D8A4-3810-43CF-810D-F3E16BCFE329Q33825406-6FBC8817-05DD-4597-8BD1-37AC54213764Q33835473-8CD60A1F-5685-47DC-85DC-3390BD700F0FQ33835479-1B3DA65C-61C2-4518-9C64-11051BC3503EQ33983315-3896AFDA-A488-4277-B877-333AE783EE3CQ34053075-2310A59F-D718-4064-9CE0-58D6BC98AC19Q34055287-1C61B301-486A-48CC-BD8A-A4743059D76FQ34081674-AF5049D0-6C5F-4D4E-B456-BF17AE7819E6Q34228659-F6A708B9-8D79-441B-89A4-C7ED436C8182Q34297293-992102B9-0193-493B-A975-A01B4DF0401DQ34414463-EBAF685E-5653-4357-B9D4-EF54A0F3473DQ34529971-1AE8A938-D8CC-47FC-916C-3FDBF655C020Q34611897-80D90CC6-60D6-40C8-A0DA-317E26F7F857Q34648207-6ACF3715-ECE9-45E9-8A09-4879E92481FCQ34648449-B45AFE28-665A-426C-A1EF-FC117AA48758Q34653920-2BE25183-A16A-4D33-8F8E-B5A5398C91D1Q34742583-ADE3FF4A-5080-40EA-BDBD-E548C6D4C5D5Q35040097-1CB2266F-3604-4CAC-BDCE-D8FC9D237424Q35040673-1E462AE2-12A4-4E0D-8118-E384E5055BD8Q35076638-486ED486-AAD0-4689-B156-BA3DFD961E3BQ35206861-83D766B9-216C-4CBE-BE0A-AC3248AB11ABQ35220880-5E4DBE2B-C1AF-42D5-BB5F-E81696FB46DFQ35275146-94757999-A732-4961-9B02-B12BFE9C8049Q35602225-D73ABEEA-2B44-4050-A37B-6C34B0F26928Q35778127-8D2798A2-6E59-4791-9F26-0EF4841AB20CQ35792771-C1FC8A88-662F-4636-8DD4-4DD1EA2AD224
P2860
Recent progress in herpes simplex virus immunobiology and vaccine research
description
2003 nî lūn-bûn
@nan
2003 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Recent progress in herpes simplex virus immunobiology and vaccine research
@ast
Recent progress in herpes simplex virus immunobiology and vaccine research
@en
type
label
Recent progress in herpes simplex virus immunobiology and vaccine research
@ast
Recent progress in herpes simplex virus immunobiology and vaccine research
@en
prefLabel
Recent progress in herpes simplex virus immunobiology and vaccine research
@ast
Recent progress in herpes simplex virus immunobiology and vaccine research
@en
P2860
P1476
Recent progress in herpes simplex virus immunobiology and vaccine research
@en
P2093
David M Koelle
Lawrence Corey
P2860
P304
P356
10.1128/CMR.16.1.96-113.2003
P407
P577
2003-01-01T00:00:00Z